BioXcel Therapeutics (BTAI) Reports Q4 Loss of $0.87/sh

Go back to BioXcel Therapeutics (BTAI) Reports Q4 Loss of $0.87/sh
(NASDAQ: BTAI) Delayed: 1.27 -0.03 (2.31%)
Previous Close $1.30    52 Week High
Open $1.28    52 Week Low
Day High $1.31    P/E N/A 
Day Low $1.25    EPS
Volume 478,983